PHK
SWTX

Point72 Hong Kong’s SpringWorks Therapeutics SWTX Stock Holding History

Point72 Hong Kong’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,571
Closed -$97K – 2297
2021
Q4 		$97K Buy
1,571
+1,049
+201% +$69.4K ﹤0.01% 1185
2021
Q3 		$33K Buy
+522
New +$40.2K ﹤0.01% 1612
2021
Q2 		– Sell
-133
Closed -$10K – 2335
2021
Q1 		$10K Sell
133
-291
-69% -$22.8K ﹤0.01% 1589
2020
Q4 		$31K Buy
+424
New +$27.3K ﹤0.01% 1336

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Point72 Hong Kong's SWTX Position: Q1 2022 in Review

Point72 Hong Kong sold out of SpringWorks Therapeutics (SWTX) in Q1 2022, closing a stake of 1,571 shares — an estimated $97K sold.

Point72 Hong Kong first reported a position in SWTX in Q4 2020 and held it in 4 quarters. The position peaked at $97K in Q4 2021. 137 funds tracked by Wall St. Rank hold SWTX as of Q1 2022.

  • Point72 Hong Kong reported no remaining SpringWorks Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,571 SpringWorks Therapeutics shares in Q1 2022, an estimated $97K.
  • Point72 Hong Kong first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 4 quarters.
  • Point72 Hong Kong's SpringWorks Therapeutics position peaked at $97K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.